Floatz logo

Equine Atg

BAL

Nantes University HospitalPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the BAL cohort.

Asset / SponsorPhaseRating
Clofarabine
Nantes University Hospital
Phase 2B
Busulphan
Nantes University Hospital
Phase 2B

Same molecule, other indications

Equine Atg is also rated in:

acute lymphoblastic leukemiaDormant
BBB
Indicative ·
72 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
BB
Indicative ·
68 / 100
View asset →
Hemoglobinuria, Paroxysmal Nocturnal (PNH)Dormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →